Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Americans stock up on Rx Drugs, while some look to disproven remedies to Protect against COVID-19

The School of Pharmacy and Health Sciences at Fairleigh Dickinson University recently surveyed adults nationwide about their worries over the availability of prescription drugs; their attitudes toward the role pharmacists could play in providing care and potential treatments; their knowledge of how the virus spreads, and what can be done to mitigate the chances of infection; and their assessment of the threat COVID-19 poses.


News provided by

Fairleigh Dickinson University

Mar 27, 2020, 16:00 ET

Share this article

Share toX

Share this article

Share toX

FDU School of Pharmacy and Health Sciences
FDU School of Pharmacy and Health Sciences

MADISON, N.J., March 27, 2020 /PRNewswire-PRWeb/ -- As the COVID-19 pandemic continues to spread across the United States, its effects are being seen in the concerns and confusion of many Americans over issues related to the virus. The School of Pharmacy and Health Sciences at Fairleigh Dickinson University recently surveyed adults nationwide about their worries over the availability of prescription drugs; their attitudes toward the role pharmacists could play in providing care and potential treatments; their knowledge of how the virus spreads, and what can be done to mitigate the chances of infection; and their assessment of the threat COVID-19 poses. Findings suggest the following:

  • Almost half of all Americans are worried that the coronavirus will make it harder for them to get their prescription drugs, and, as a result, many are increasing their refill to a 90-day supply, as well as visiting their doctors and pharmacists for assistance. Some are taking steps that could potentially endanger their health by taking medications less often than prescribed in order to stretch out their available supply.
  • Although the vast majority of Americans know that the virus can be transmitted by coughing, some Americans believe in sources of transmission that are simply false, including mosquitos and exposure to cold weather.
  • The message of "social distancing" as a way to minimize one's risk of becoming infected is getting through, but some Americans falsely believe that taking hot baths and using alcohol/vodka on one's body will minimize the risk of being infected with the coronavirus.
  • Even though COVID-19 is a new virus, a majority of Americans would not hesitate to receive a vaccine should it become available most Americans would feel confident relying on their pharmacist for testing and treatment if their doctor was unavailable which could help relieve some of the strain on other healthcare providers.

“In light of the pandemic, expanding pharmacists’ authority to refill prescriptions for chronically ill patients without a physician’s authorization could relieve some of the stress on the healthcare system and help ensure patients have access to necessary medications,” said Dr. Kalabalik-Hoganson.

Post this

Prescription drugs and Care Providers
As the president touts the promising nature of certain prescription drugs for treating the virus, concerns are mounting that Americans will begin to experience difficulty in getting their currently prescribed medications. The supply chain worries many, with 41% somewhat or very worried that their drugs will become more difficult to get as a result of COVID-19. Republicans (62%) and seniors (63%) are the least worried about prescription drug supplies.

"There are reasons for concern over drug shortages since China, the largest producer and exporter of active pharmaceutical ingredients, and India, a major producer of generic drugs, have both been severely impacted by COVID-19, said Julie Kalabalik-Hoganson, PharmD, BCPS, BCCCP, Fairleigh Dickenson University School of Pharmacy and Health Sciences. "While the U.S. Food and Drug Administration (FDA) is carefully monitoring the drug supply chain, potential drug shortages will depend on the duration of the pandemic and how quickly pharmaceutical manufacturers can recover and get back to full production."

Those who are worried are taking various steps to ensure they have enough medication on hand in the coming weeks and months including, increasing their refills to a 90-day supply (53%), seeing their doctor (43%) or pharmacist (38%) for assistance, taking their medications less frequently in order to make them last longer (19%), and switching medications (8%).

"In light of the pandemic, expanding pharmacists' authority to refill prescriptions for chronically ill patients without a physician's authorization could relieve some of the stress on the healthcare system and help ensure patients have access to necessary medications," said Dr. Kalabalik-Hoganson. "Additionally, authorizing pharmacists to perform coronavirus testing could help expand patient access to tests, reduce the spread of disease, reduce visits to overflowing emergency rooms and doctor's offices, and improve patient outcomes. Since 90 percent of Americans live within five miles of a pharmacy, point-of-care testing by pharmacists at temporary areas set up outside of drugstores will expand patient access to tests and getting them results more quickly."

The survey confirms Americans' willingness to have pharmacists provide care when physicians are not accessible. More than eight-in-ten would turn to their pharmacist for coronavirus testing (84%) and treatment (85%), with over half saying they are very likely to do so if their doctor is unavailable.

It also affirms Americans' interest in utilizing a COVID-19 vaccine, with 84 percent who say they would be likely to get inoculated if a vaccine became available. A sizable partisan difference separates Americans on this issue with fewer than half of Republicans (45%) as compared with 63 percent of Democrats who are "very likely" to do so.

How does it spread? What keeps you safe?
Information on how the coronavirus is transmitted has been widely disseminated; however, some Americans are still misinformed. While almost everyone (93%) correctly identifies coughing as a source of transmission, 17% believe exposure to cold weather puts them at risk for the virus and 13 percent say they can get COVID-19 from mosquitos – both of which are inaccurate. These disproven beliefs are more common among millennials and non-whites.

The message that social distancing is critical for stemming the spread of COVID-19 has definitely been heard. Ninety-six percent of all adults say distancing oneself from others is key to risk mitigation. Significantly fewer, but still around a quarter of all adults, also believe in disproven theories: 29 percent believe using hand dryers is effective, 27 percent believe spraying alcohol on one's body works, 24 percent say taking hot baths is helpful, and six percent believe in the use of vodka as a spray disinfectant to ward off the virus.

"While there has been a great deal of good information relayed to the public about COVID-19 facts, it is evident that many myths about the virus exist, continued Dr. Kalabalik-Hoganson. During a time of information overload, the public needs accurate sources of information in order to take appropriate measures to protect themselves and others."

Threats vs. Hype
Finally, despite the claims by some that the virus is more an artifact of media hype rather than a real threat to the nation's health, a clear majority reject this belief. Sixty-nine percent believe the virus is a genuine threat, with a quarter (26%) who distrust media accounts of the pandemic. Self-identified Republicans are the least likely to believe the virus is a threat (59%) and the most likely (35%) to distrust media accounts as compared with democrats and independents.

"This is a rapidly changing story, and the landscape has already changed from when the interviews for this survey concluded a few days ago. Still, it's notable that one-in-four are suspicious of what they're hearing about the virus," said Krista Jenkins, professor of politics and government and director of the FDU Poll. "Trust in leaders and institutions like the media is key to getting through a nationwide threat like COVID-19. Unfortunately, the American public goes into this with an already deep well of distrust for political leaders and institutions,"

Americans also give President Trump a middling grade on whether his leadership has been helpful or harmful during the crisis. When asked on a scale of 0 to 10, with 0 meaning harmful and 10 meaning helpful, the average score was 5.9. Those with a HS degree or less (6.7) and Republicans (8.2) offer the highest appraisals, with Democrats (3.7) grading him the worst.

Methodology and tables can be found here:

SOURCE Fairleigh Dickinson University

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.